Hostname: page-component-7c8c6479df-94d59 Total loading time: 0 Render date: 2024-03-28T14:59:27.924Z Has data issue: false hasContentIssue false

Correlation between Rates of Carbapenem Consumption and the Prevalence of Carbapenem-Resistant Pseudomonas aeruginosa in a Tertiary Care Hospital in Brazil: A 4-Year Study

Published online by Cambridge University Press:  02 January 2015

Guilherme H. C. Furtado*
Affiliation:
Hospital Epidemiology Committee, Division of Infectious Diseases, Federal University of São Paulo, São Paulo, Brazil
Luciana B. Perdiz
Affiliation:
Hospital Epidemiology Committee, Division of Infectious Diseases, Federal University of São Paulo, São Paulo, Brazil
Julio H. Onita
Affiliation:
Hospital Epidemiology Committee, Division of Infectious Diseases, Federal University of São Paulo, São Paulo, Brazil
Sérgio B. Wey
Affiliation:
Hospital Epidemiology Committee, Division of Infectious Diseases, Federal University of São Paulo, São Paulo, Brazil
Eduardo A. S. Medeiros
Affiliation:
Hospital Epidemiology Committee, Division of Infectious Diseases, Federal University of São Paulo, São Paulo, Brazil
*
R. Dr. Diogo de Faria 1226, Apt 72, São Paulo-SP, Brazil, 04037-004, (ghfurtado@uol.com.br)
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2010

References

1.Paramythiotou, E, Lucet, JC, Timsit, JF, et al.Acquisition of multidrug-resistant Pseudomonas aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity. Clin Infect Dis 2004;38:670677.Google Scholar
2.Harris, AD, Smith, D, Johnson, JA, Bradham, DD, Roghmann, MC. Risk factors for imipenem-resistant Pseudomonas aeruginosa among hospitalized patients. Clin Infect Dis 2002;34:340345.Google Scholar
3.Troillet, N, Samore, MH, Carmeli, Y. Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns. Clin Infect Dis 1997;25:10941098.CrossRefGoogle ScholarPubMed
4.Mutnick, AH, Rhomberg, PR, Sader, HS, Jones, RN. Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001). J Antimicrob Chemother 2004;53:290296.CrossRefGoogle ScholarPubMed
5.Hsueh, PR, Chen, WH, Luh, KT. Relationships between antimicrobial use and antimicrobial resistance in gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan. Int J Antimicrob Agents 2005;26:463472.CrossRefGoogle Scholar
6.Meyer, E, Schwab, F, Gastmeier, P, Rueden, H, Daschner, FD. Surveillance of antimicrobial use and antimicrobial resistance in German intensive care units (SARI): a summary of the data from 2001 through 2004. Infection 2006;34:303309.CrossRefGoogle Scholar
7.Iosifidis, E, Antachopoulos, C, Tsivitanidou, M, et al.Differencial correlation between rates of antimicrobial drug consumption and prevalence of antimicrobial resistance in a tertiary care hospital in Greece. Infect Control Hosp Epidemiol 2008;29:615622.CrossRefGoogle Scholar
8.Patzer, JA, Dzierzanowska, D, Turner, PJ. Trends in antimicrobial susceptibility of gram-negative isolates from a paediatric intensive care unit in Warsaw: results from the MYSTIC programme (1997-2007). J Antimicrob Chemother 2008;62:369375.CrossRefGoogle ScholarPubMed
9.Messadi, AA, Lamia, T, Kamel, B, Salima, O, Monia, M, Saida, BR. Association between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in an intensive care burn unit: a 5-year study, 2000-2004. Burns 2008;34:10981102.Google Scholar
10.Lautenbach, E, Weiner, MG, Nachamkin, I, Bilker, WB, Sheridan, A, Fishman, NO. Imipenem resistance among Pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes. Infect Control Hosp Epidemiol 2006;27:893900.CrossRefGoogle ScholarPubMed